Nitric Oxide and Angiogenesis

HomeCirculationVol. 105, No. 18Nitric Oxide and Angiogenesis Free AccessEditorialPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessEditorialPDF/EPUBNitric Oxide and Angiogenesis John P. Cooke and Douglas W. Losordo John P. CookeJohn P. Cooke From the Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, Calif. Search for more papers by this author and Douglas W. LosordoDouglas W. Losordo From the Division of Cardiovascular Medicine, Stanford University School of Medicine, Stanford, Calif. Search for more papers by this author Originally published7 May 2002https://doi.org/10.1161/01.CIR.0000014928.45119.73Circulation. 2002;105:2133–2135Endothelium-derived nitric oxide (NO) is a mediator of angiogenesis. Vascular endothelial growth factor (VEGF) stimulates the release of NO from cultured human umbilical venous endothelial cells and upregulates the expression of nitric oxide synthase (NOS).1,2 Segments of rabbit thoracic aorta release NO in response to VEGF; preincubation with l-arginine increases basal and VEGF-stimulated NO release 2-fold.2 Similar results are observed when the angiogenic stimulus is transforming growth factor β or basic fibroblast growth factor.3–5See p 2185The release of NO by these factors plays a critical role in their angiogenic actions. In a 3D fibrin gel, human umbilical venous endothelial cells elaborate NO and form capillary-like structures when stimulated by basic fibroblast growth factor or VEGF, effects that are blocked by the NOS antagonist Nw-nitro-l-arginine methyl ester (L-NAME).6,7 Similar effects have been observed in vitro using substance P or transforming growth factor β.8,9 In the rabbit cornea model of angiogenesis, VEGF-induced angiogenesis is antagonized by L-NAME.10Angiogenesis is attenuated when NO bioactivity is reduced. Capillary-like outgrowths sprout from segments of rabbit thoracic aorta or human coronary artery explanted into a collagen matrix. This ex vivo angiogenesis is inhibited by oxidized LDL cholesterol,11,12 an agent also known to reduce NO bioactivity. In hypercholesterolemic rabbits, endothelium-dependent NO-mediated vasodilation is blunted, as is the angiogenic response to hindlimb ischemia.13 More definitively, the angiogenic response to hindlimb ischemia is impaired in the eNOS-deficient mice, an effect that cannot be reversed by administration of recombinant VEGF protein or adenovirus-mediated VEGF gene transfer.14How Does NO Exert Its Angiogenic Effects?The mechanisms by which NO promotes angiogenesis are not fully elucidated. NO is an endothelial survival factor, inhibiting apoptosis15,16 and enhancing endothelial cell proliferation, perhaps in part by increasing the expression of VEGF or fibroblast growth factor.17,18 NO also enhances endothelial migration9,14 by stimulating endothelial cell podokinesis,19 enhancing the expression of αvβ3,14 and increasing dissolution of the extracellular matrix via the basic fibroblast growth factor–induced upregulation of urokinase-type plasminogen activator.18 Finally, the hemodynamic effects of this potent vasodilator may play a role in its angiogenic effects. It is known that increased flow (induced by prazosin) in the skeletal microcirculation is associated with increased endothelial cell proliferation, as indicated by uptake of bromodeoxyuridine by capillary endothelial cells.20A new mechanism by which NO may influence angiogenesis is reported in the article by Matsunaga et al21 in the present issue of Circulation. These investigators suggest that NO may suppress the production of angiostatin, an endogenous antagonist of angiogenesis.NO and AngiostatinMatsunaga and colleagues21 examined myocardial tissue and interstitial fluid from dogs undergoing repetitive coronary artery occlusions in the presence of vehicle or L-NAME, an antagonist of NO synthase. At 7 days, there was an increase in capillary density in the ischemic zone of those animals receiving vehicle, which was suppressed in those animals receiving L-NAME. Interstitial fluid from the ischemic myocardium of the control animals (but not sham-operated animals) induced endothelial cell proliferation and capillary tube formation in vitro. This effect of the interstitial fluid was suppressed in those animals receiving L-NAME. Western analysis of the interstitial fluid from the L-NAME–treated animals revealed a marked increase in angiostatin levels. Angiostatin seemed to be mediating the antiangiogenic effects of L-NAME; antiangiostatin antibody restored the angiogenic effect of the interstitial fluid from the ischemic myocardium of the L-NAME–treated animals.Angiostatin is a known inhibitor of angiogenesis22 that is generated from the degradation of plasminogen by matrix metalloproteinases (MMPs). The investigators noted that MMP-2 and MMP-9 activity was increased in the myocardium of L-NAME–treated animals and in the conditioned medium of endothelial cells treated with L-NAME. Presumably, the increased activity of MMP-2 and MMP-9 increased the generation of angiostatin. The same mechanism for release of angiogenic factors from the interstitium may contribute to the neovascularization that occurs in certain types of arthritis.23 These findings are also consistent with prior reports indicating that angiostatin is liberated by metalloelastase activity of macrophages in certain tumors.24. The role of MMPs in an antiangiogenic effect seems somewhat paradoxical, in that dissolution of extracellular matrix is needed for endothelial cell migration, a critical process in angiogenesis. Most biological processes, however, trigger countervailing effects that modulate response. Undoubtedly, such countervailing forces, not yet defined, explain the observation by Matsunaga et al21 that, at later time points, myocardial capillary density declines in the control animals despite repetitive ischemic stimuli.The complexities of angiogenesis and the NO synthase pathway become ever more convoluted in the context of atherosclerosis. A pathological role has been assigned to neovascularization on the basis of experimental evidence that antiangiogenic drugs inhibit plaque growth, whereas angiogenic factors accelerate it.25–27 We are presented with a paradox: The ability of the endothelium to produce NO is reflective of arterial health, yet NO mediates angiogenesis. Could NO, under certain circumstances, contribute to plaque growth—for example, by favoring neovascularization? We think not. NO is a pleiotropic factor, with many actions that oppose atherogenesis (eg, its inhibition of platelet aggregation, monocyte adherence, and oxidant-sensitive genes involved in atherogenesis).28 When all of the actions of NO are considered in the balance, NO seems to be an antiatherosclerotic factor. Our view is supported by studies showing that genetic or pharmacological abrogation of the NO synthase pathway invariably accelerates atherosclerosis.28,29Of relevance to this discussion is the existence of an endogenous antagonist to NO synthase. Asymmetric dimethylarginine (ADMA) is an arginine analogue that competes with l-arginine for NOS.30 Plasma ADMA levels are elevated in animals and humans with hypercholesterolemia, diabetes mellitus, hypertension, homocystinemia, tobacco use, relatively advanced age, or congestive heart failure.30 In experimental animal models, endogenous or exogenously elevated plasma ADMA levels are associated with impaired angiogenic response to ischemia, an effect that is reversed by supplemental l-arginine.31ConclusionTo conclude, the study by Matsunaga et al21 provides more evidence that NO plays a critical role in angiogenesis. As we pursue therapeutic angiogenesis for the treatment of vascular occlusive disease, it will be important to consider the role that restoration of endothelial health may play. Certainly, VEGF can enhance endothelial regeneration, restore endothelial function, and stimulate angiogenesis.32 Aggressive treatment of comorbid conditions (eg, hypercholesterolemia, hypertension, diabetes, and tobacco exposure) to restore endothelial function, however, may be just as important as the administration of gene therapies or recombinant angiogenic proteins in the success of therapeutic angiogenesis.The opinions expressed in this editorial are not necessarily those of the editors or of the American Heart Association.FootnotesCorrespondence to John P. Cooke, Division of Cardiovascular Medicine, Stanford University School of Medicine, 300 Pasteur Dr, Stanford, CA 94305-5406. E-mail [email protected] References 1 Hood JD, Meininger CJ, Ziche M, et al. VEGF upregulates ecNOS message, protein, and NO production in human endothelial cells. Am J Physiol. 1998; 274(3 Pt 2): H1054–H1058.Google Scholar2 van der Zee R, Murohara T, Luo Z, et al. Vascular endothelial growth factor/vascular permeability factor augments nitric oxide release from quiescent rabbit and human vascular endothelium. Circulation. 1997; 95: 1030–1037.CrossrefMedlineGoogle Scholar3 Inoue N, Venema RC, Sayegh HS, et al. Molecular regulation of the bovine endothelial cell nitric oxide synthase by transforming growth factor-beta 1. Arterioscler Thromb Vasc Biol. 1995; 15: 1255–1261.CrossrefMedlineGoogle Scholar4 Wu HM, Yuan Y, McCarthy M, et al. Acidic and basic FGFs dilate arterioles of skeletal muscle through a NO-dependent mechanism. Am J Physiol. 1996; 271(3 Pt 2): H1087–H1093.Google Scholar5 Tiefenbacher CP, Chilian WM. Basic fibroblast growth factor and heparin influence coronary arteriolar tone by causing endothelium-dependent dilation. Cardiovas Res. 1997; 34: 411–417.CrossrefMedlineGoogle Scholar6 Babaei S, Teichert-Kuliszewska K, Monge JC, et al. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ Res. 1998; 82: 1007–1015.CrossrefMedlineGoogle Scholar7 Papapetropoulos A, Garcia-Cardena G, Madri JA, et al. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 1997; 100: 3131–3139.CrossrefMedlineGoogle Scholar8 Papapetropoulos A, Desai KM, Rudic RD, et al. Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. Am J Pathol. 1997; 150: 1835–1844.MedlineGoogle Scholar9 Ziche M, Morbidelli L, Masini E, et al. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest. 1994; 94: 2036–2044.CrossrefMedlineGoogle Scholar10 Ziche M, Morbidelli L, Choudhuri R, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibroblast growth factor-induced angiogenesis. J Clin Invest. 1997; 99: 2625–2634.CrossrefMedlineGoogle Scholar11 Chen CH, Cartwright J Jr, Li Z, et al. Inhibitory effects of hypercholesterolemia and ox-LDL on angiogenesis-like endothelial growth in rabbit aortic explants: essential role of fibroblast growth factor. Arterioscler Thromb Vasc Biol. 1997; 17: 1303–1312.CrossrefMedlineGoogle Scholar12 Chen CH, Henry PD. Atherosclerosis as a microvascular disease: impaired angiogenesis mediated by suppressed basic fibroblast growth factor expression. Proc Assoc Am Physicians. 1997; 109: 351–361.MedlineGoogle Scholar13 Van Belle E, Rivard A, Chen D, et al. Hypercholesterolemia attenuates angiogenesis but does not preclude augmentation by angiogenic cytokines. Circulation. 1997; 96: 2667–2674.CrossrefMedlineGoogle Scholar14 Murohara T, Witzenbichler B, Spyridopoulos I, et al. Role of endothelial nitric oxide synthase in endothelial cell migration. Arterioscler Thromb Vasc Biol. 1999; 19: 1156–1161.CrossrefMedlineGoogle Scholar15 Dimmeler S, Hermann C, Galle J, et al. Upregulation of superoxide dismutase and nitric oxide synthase mediates the apoptosis-suppressive effects of shear stress on endothelial cells. Arterioscler Thromb Vasc Biol. 1999; 19: 656–664.CrossrefMedlineGoogle Scholar16 Rossig L, Fichtlscherer B, Breitschopf K, et al. Nitric oxide inhibits caspase-3 by S-nitrosation in vivo. J Biol Chem. 1999; 274: 6823–6826.CrossrefMedlineGoogle Scholar17 Dulak J, Jozkowicz A, Dembinska-Kiec A, et al. Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 2000; 20: 659–666.CrossrefMedlineGoogle Scholar18 Ziche M, Parenti A, Ledda F, et al. Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF. Circ Res. 1997; 80: 845–852.CrossrefMedlineGoogle Scholar19 Noiri E, Lee E, Testa J, et al. Podokinesis in endothelial cell migration: role of nitric oxide. Am J Physiol. 1998; 274(1 Pt 1): C236–C244.Google Scholar20 Hudlicka O. Is physiological angiogenesis in skeletal muscle regulated by changes in microcirculation? Microcirculation. 1998; 5: 7–23.CrossrefMedlineGoogle Scholar21 Matsunaga T, Weihrauch DW, Moniz MC, et al. Angiostatin inhibits coronary angiogenesis during impaired production of nitric oxide. Circulation. 2002; 105: 2185–2191.LinkGoogle Scholar22 O’Reilly MS, Holmgren L, Shing Y, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994; 79: 315–328.CrossrefMedlineGoogle Scholar23 Tamura T, Nakanishi T, Kimura Y, et al. Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis. Endocrinology. 1996; 137: 3729–3737.CrossrefMedlineGoogle Scholar24 Dong Z, Kumar R, Yang X, et al. Macrophage-derived metalloelastase is responsible for the generation of angiostatin in Lewis lung carcinoma. Cell. 1997; 88: 801–810.CrossrefMedlineGoogle Scholar25 Moulton KS, Heller E, Konerding MA, et al. Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation. 1999; 99: 1726–1732.CrossrefMedlineGoogle Scholar26 Celletti FL, Waugh JM, Amabile PG, et al. Vascular endothelial growth factor enhances atherosclerotic plaque progression. Nature Med. 2001; 7: 425–429.CrossrefMedlineGoogle Scholar27 Heeschen C, Jang J, Hoai-Ky V, et al. Nicotine is an agent of angiogenesis. Nat Med. 2001; 7: 833–839.CrossrefMedlineGoogle Scholar28 Maxwell AJ, Cooke JP. The role of nitric oxide in atherosclerosis. Coron Artery Dis. 1999; 10: 277–286.CrossrefMedlineGoogle Scholar29 Chen J, Kuhlencordt PJ, Astern J, et al. Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation. 2001; 104: 2391–2394.CrossrefMedlineGoogle Scholar30 Cooke JP. Does ADMA cause endothelial dysfunction? Arterioscler Thromb Vasc Biol. 2000; 20: 2032–2037.CrossrefMedlineGoogle Scholar31 Jang J, Ho H-K, Kwan HH, et al. Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine. Circulation. 2000; 102: 1414–1419.CrossrefMedlineGoogle Scholar32 Losordo DW, Isner JM. Vascular endothelial growth factor-induced angiogenesis: crouching tiger or hidden dragon? J Am Coll Cardiol. 2001; 37: 2131–2135.CrossrefMedlineGoogle Scholar eLetters(0)eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.Sign In to Submit a Response to This Article Previous Back to top Next FiguresReferencesRelatedDetailsCited By Saati-Zarei A, Damirchi A, Tousi S and Babaei P (2023) Myocardial angiogenesis induced by concurrent vitamin D supplementation and aerobic-resistance training is mediated by inhibiting miRNA-15a, and miRNA-146a and upregulating VEGF/PI3K/eNOS signaling pathway, Pflügers Archiv - European Journal of Physiology, 10.1007/s00424-023-02788-x, 475:4, (541-555), Online publication date: 1-Apr-2023. Zhang D, Jin C, Han T, Chen J, Ali Raza M, Li B, Wang L and Yan H (2023) Sinomenine promotes flap survival by upregulating eNOS and eNOS-mediated autophagy via PI3K/AKT pathway, International Immunopharmacology, 10.1016/j.intimp.2023.109752, 116, (109752), Online publication date: 1-Mar-2023. Fournier L, de La Taille T and Chauvierre C (2023) Microbubbles for human diagnosis and therapy, Biomaterials, 10.1016/j.biomaterials.2023.122025, 294, (122025), Online publication date: 1-Mar-2023. Ben Moftah M and Eswayah A (2023) Hydroxyurea as a promising ADAM17 inhibitor, Medical Hypotheses, 10.1016/j.mehy.2023.111021, 171, (111021), Online publication date: 1-Feb-2023. Penasso H, Petersen F and Peternell G (2023) Vascular and Neural Response to Focal Vibration, Sensory Feedback, and Piezo Ion Channel Signaling, Journal of Vascular Diseases, 10.3390/jvd2010006, 2:1, (42-90) Wang P, Pu Y, Ren Y, Kong W, Xu L, Zhang W, Shi T, Ma J, Li S, Tan X and Chi B (2023) Enzyme-regulated NO programmed to release from hydrogel-forming microneedles with endogenous/photodynamic synergistic antibacterial for diabetic wound healing, International Journal of Biological Macromolecules, 10.1016/j.ijbiomac.2022.12.063, 226, (813-822), Online publication date: 1-Jan-2023. Rong F, Wang T, Zhou Q, Peng H, Yang J, Fan Q and Li P (2023) Intelligent polymeric hydrogen sulfide delivery systems for therapeutic applications, Bioactive Materials, 10.1016/j.bioactmat.2022.03.043, 19, (198-216), Online publication date: 1-Jan-2023. Erarslan S and Coskun-Cevher S (2023) The Effects of FGF2 Application on Oxidative Status of Wound Tissue in Normo- and Hyperglycemic Rats: A Time-Based Study, Biology Bulletin, 10.1134/S1062359022140059, 49:S2, (S122-S129), Online publication date: 1-Dec-2022. Flournoy J, Ashkanani S and Chen Y (2022) Mechanical regulation of signal transduction in angiogenesis, Frontiers in Cell and Developmental Biology, 10.3389/fcell.2022.933474, 10 Zhao Y, Sun Y, Hang R, Yao R, Zhang Y, Huang D, Yao X, Bai L and Hang R (2022) Biocompatible silane adhesion layer on titanium implants improves angiogenesis and osteogenesis, Biomaterials Advances, 10.1016/j.bioadv.2022.213033, 139, (213033), Online publication date: 1-Aug-2022. Kamel R, El Morsy E, Elsherbiny M and Nour‐Eldin M (2022) Chrysin promotes angiogenesis in rat hindlimb ischemia: Impact on PI3K/Akt/mTOR signaling pathway and autophagy, Drug Development Research, 10.1002/ddr.21954, 83:5, (1226-1237), Online publication date: 1-Aug-2022. HAKSEVEN M, KAPAN M, ALABALIK U and AVŞAR G (2022) Comparing The Effects Of Sildenafil Citrate And Dexpanthenol On Wound Healing: An Experimental Study, SDÜ Tıp Fakültesi Dergisi, 10.17343/sdutfd.1100763 Bellanti F, Vendemiale G and Serviddio G Redox experimental medicine and liver regeneration, Redox Experimental Medicine, 10.1530/REM-22-0008, 2022:1, (R69-R82) Zhang Q, Cannavicci A, Kutryk M and Mandraffino G (2022) Exploring Endothelial Colony-Forming Cells to Better Understand the Pathophysiology of Disease: An Updated Review, Stem Cells International, 10.1155/2022/4460041, 2022, (1-14), Online publication date: 16-May-2022. Souza R, Martinelli-Kläy C, d’Acampora A, Bernardes G, Sgrott S, Souza L, Lombardi T and Sudbrack T (2021) Effects of sildenafil and tadalafil on skin flap viability, Archives of Dermatological Research, 10.1007/s00403-021-02196-0, 314:2, (151-157), Online publication date: 1-Mar-2022. Yang C, Chung N, Song C, Youm H, Lee K and Lee J (2021) Promotion of angiogenesis toward transplanted ovaries using nitric oxide releasing nanoparticles in fibrin hydrogel, Biofabrication, 10.1088/1758-5090/ac3f28, 14:1, (011001), Online publication date: 1-Jan-2022. Berenyiova A, Bernatova I, Zemancikova A, Drobna M, Cebova M, Golas S, Balis P, Liskova S, Valaskova Z, Krskova K, Zorad S, Dayar E and Cacanyiova S (2021) Vascular Effects of Low-Dose ACE2 Inhibitor MLN-4760—Benefit or Detriment in Essential Hypertension?, Biomedicines, 10.3390/biomedicines10010038, 10:1, (38) Huang L, Liang W, Zhou K, Wassel R, Ridge Z, Ma J and Wang B (2021) Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization, Biology, 10.3390/biology10121328, 10:12, (1328) Zhu Q, Zhang Y, Tang J, Tang N, He Y, Chen X, Gao S, Xu Y and Liu Z (2021) Ultrasound-Targeted Microbubble Destruction Accelerates Angiogenesis and Ameliorates Left Ventricular Dysfunction after Myocardial Infarction in Mice, Ultrasound in Medicine & Biology, 10.1016/j.ultrasmedbio.2021.04.024, 47:9, (2692-2701), Online publication date: 1-Sep-2021. Ling Z, Chen Z, Deng J, Wang Y, Yuan B, Yang X, Lin H, Cao J, Zhu X and Zhang X (2021) A novel self-healing polydopamine-functionalized chitosan-arginine hydrogel with enhanced angiogenic and antibacterial activities for accelerating skin wound healing, Chemical Engineering Journal, 10.1016/j.cej.2021.130302, 420, (130302), Online publication date: 1-Sep-2021. Xie X, Liang J, Huang R, Luo C, Yang J, Xing H, Zhou L, Qiao H, Ergu E and Chen H (2021) Molecular pathways underlying tissue injuries in the bladder with ketamine cystitis, The FASEB Journal, 10.1096/fj.202100437, 35:7, Online publication date: 1-Jul-2021. Yan J, Xia D, Xiong P, Li Y, Zhou W, Li Q, Wang P, Zheng Y and Cheng Y (2021) Polyetheretherketone with citrate potentiated influx of copper boosts osteogenesis, angiogenesis, and bacteria-triggered antibacterial abilities, Journal of Materials Science & Technology, 10.1016/j.jmst.2020.08.048, 71, (31-43), Online publication date: 1-Apr-2021. Colombo E, Signore A, Aicardi S, Zekiy A, Utyuzh A, Benedicenti S and Amaroli A (2021) Experimental and Clinical Applications of Red and Near-Infrared Photobiomodulation on Endothelial Dysfunction: A Review, Biomedicines, 10.3390/biomedicines9030274, 9:3, (274) Chen C, Dai P, Nan L, Lu R, Wang X, Tian Y, Zhang X, Gao Y, Zheng S and Zhang Y (2020) Isolation and characterization of endothelial progenitor cells from canine bone marrow, Biotechnic & Histochemistry, 10.1080/10520295.2020.1762001, 96:2, (85-93), Online publication date: 17-Feb-2021. Zippusch S, Helms F, Lau S, Klingenberg M, Schrimpf C, Haverich A, Wilhelmi M and Böer U (2020) Perfusion promotes endothelialized pore formation in high concentration fibrin gels otherwise unsuitable for tube development, The International Journal of Artificial Organs, 10.1177/0391398820936700, 44:2, (130-138), Online publication date: 1-Feb-2021. Palacios J, Benites J, Owen G, Morales P, Chiong M, Nwokocha C, Paredes A and Cifuentes F (2021) Impact of the Potential Antitumor Agent 2-(4-Hydroxyphenyl) Amino-1,4-Naphthoquinone (Q7) on Vasomotion Is Mediated by the Vascular Endothelium, But Not Vascular Smooth Muscle Cell Metabolism, Journal of Cardiovascular Pharmacology, 10.1097/FJC.0000000000000940, 77:2, (245-252) Goel M, Varandani R and Okwuosa T (2020) Resistance to antihypertensive drugs targeting Renin-Angiotensin-Aldosterone-System in cancer patients: a case series, Cardio-Oncology, 10.1186/s40959-020-00071-x, 6:1, Online publication date: 1-Dec-2020. Busco G, Robert E, Chettouh-Hammas N, Pouvesle J and Grillon C (2020) The emerging potential of cold atmospheric plasma in skin biology, Free Radical Biology and Medicine, 10.1016/j.freeradbiomed.2020.10.004, 161, (290-304), Online publication date: 1-Dec-2020. Ravoor J, Amirthalingam S, Mohan T and Rangasamy J (2020) Antibacterial, anti-biofilm and angiogenic calcium sulfate-nano MgO composite bone void fillers for inhibiting Staphylococcus aureus infections, Colloid and Interface Science Communications, 10.1016/j.colcom.2020.100332, 39, (100332), Online publication date: 1-Nov-2020. Belviso I, Angelini F, Di Meglio F, Picchio V, Sacco A, Nocella C, Romano V, Nurzynska D, Frati G, Maiello C, Messina E, Montagnani S, Pagano F, Castaldo C and Chimenti I (2020) The Microenvironment of Decellularized Extracellular Matrix from Heart Failure Myocardium Alters the Balance between Angiogenic and Fibrotic Signals from Stromal Primitive Cells, International Journal of Molecular Sciences, 10.3390/ijms21217903, 21:21, (7903) Yan J, Xia D, Zhou W, Li Y, Xiong P, Li Q, Wang P, Li M, Zheng Y and Cheng Y (2020) pH-responsive silk fibroin-based CuO/Ag micro/nano coating endows polyetheretherketone with synergistic antibacterial ability, osteogenesis, and angiogenesis, Acta Biomaterialia, 10.1016/j.actbio.2020.07.062, 115, (220-234), Online publication date: 1-Oct-2020. Kapil V, Khambata R, Jones D, Rathod K, Primus C, Massimo G, Fukuto J, Ahluwalia A and Garland C (2020) The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-Nitrite-Nitric Oxide Pathway, Pharmacological Reviews, 10.1124/pr.120.019240, 72:3, (692-766), Online publication date: 1-Jul-2020. Kang M, Kim H, You J, Choi Y, Kwon B, Park C, Baek W, Kim M, Lee Y, Im G, Yoon J, Lee J and Sung H (2020) Hydrogel cross-linking–programmed release of nitric oxide regulates source-dependent angiogenic behaviors of human mesenchymal stem cell, Science Advances, 10.1126/sciadv.aay5413, 6:9, Online publication date: 28-Feb-2020. Esteban S, Clemente C, Koziol A, Gonzalo P, Rius C, Martínez F, Linares P, Chaparro M, Urzainqui A, Andrés V, Seiki M, Gisbert J and Arroyo A (2019) Endothelial MT 1‐ MMP targeting limits intussusceptive angiogenesis and colitis via TSP1/nitric oxide axis , EMBO Molecular Medicine, 10.15252/emmm.201910862, 12:2, Online publication date: 7-Feb-2020. Wei X, Guan L, Fan P, Liu X, Liu R, Liu Y and Bai H (2020) Direct Current Electric Field Stimulates Nitric Oxide Production and Promotes NO-Dependent Angiogenesis: Involvement of the PI3K/Akt Signaling Pathway, Journal of Vascular Research, 10.1159/000506517, 57:4, (195-205), . Strang H, Kaul A, Parikh U, Masri L, Saravanan S, Li H, Miao Q and Balaji S (2020) Role of cytokines and chemokines in wound healing Wound Healing, Tissue Repair, and Regeneration in Diabetes, 10.1016/B978-0-12-816413-6.00011-3, (197-235), . Ismail Y and Reinwald Y (2020) Hybrid Composite for Orthopedic Applications Composite Materials: Applications in Engineering, Biomedicine and Food Science, 10.1007/978-3-030-45489-0_14, (319-331), . Atkin L, Stephenson J and Ousey K (2019) Feasibility study to evaluate cycloidal vibration therapy for the symptomatic treatment of intermittent claudication, Pilot and Feasibility Studies, 10.1186/s40814-019-0514-6, 5:1, Online publication date: 1-Dec-2019. Oe Y, Fushima T, Sato E, Sekimoto A, Kisu K, Sato H, Sugawara J, Ito S and Takahashi N (2019) Protease-activated receptor 2 protects against VEGF inhibitor-induced glomerular endothelial and podocyte injury, Scientific Reports, 10.1038/s41598-019-39914-8, 9:1, Online publication date: 1-Dec-2019. Hassanshahi M, Su Y, Khabbazi S, Fan C, Tang Q, Wen X, Fan J, Chen K and Xian C (2019) Retracted : Icariin attenuates methotrexate chemotherapy‐induced bone marrow microvascular damage and bone loss in rats , Journal of Cellular Physiology, 10.1002/jcp.28326, 234:9, (16549-16561), Online publication date: 1-Sep-2019. Gu Y, Zhang J, Zhang X, Liang G, Xu T and Niu W (2019) Three-dimensional Printed Mg-Doped β-TCP Bone Tissue Engineering Scaffolds: Effects of Magnesium Ion Concentration on Osteogenesis and Angiogenesis In Vitro, Tissue Engineering and Regenerative Medicine, 10.1007/s13770-019-00192-0, 16:4, (415-429), Online publication date: 1-Aug-2019. Hassanshahi M, Su Y, Khabbazi S, Fan C, Chen K, Wang J, Qian A, Howe P, Yan D, Zhou H and Xian C (2018) Flavonoid genistein protects bone marrow sinusoidal blood vessels from damage by methotrexate therapy in rats, Journal of Cellular Physiology, 10.1002/jcp.27785, 234:7, (11276-11286), Online publication date: 1-Jul-2019. Gaspar D, Peixoto R, De Pieri A, Striegl B, Zeugolis D and Raghunath M (2019) Local pharmacological induction of angiogenesis: Drugs for cells and cells as drugs, Advanced Drug Delivery Reviews, 10.1016/j.addr.2019.06.002, 146, (126-154), Online publication date: 1-Jun-2019. Joseph C, McCarthy C, Tyo A, Hubbard K, Fisher H, Altscheffel J, He W, Pinnaratip R, Liu Y, Lee B and Rajachar R (2018) Development of an Injectable Nitric Oxide Releasing Poly(ethylene) Glycol-Fibrin Adhesive Hydrogel, ACS Biomaterials Science & Engineering, 10.1021/acsbiomaterials.8b01331, 5:2, (959-969), Online publication date: 11-Feb-2019. Hipskind S, Grover F, Fort T, Helffenstein D, Burke T, Quint S, Bussiere G, Stone M and Hurtado T (2019) Pulsed Transcranial Red/Near-Infrared Light Therapy Using Light-Emitting Diodes Improves Cerebral Blood Flow and Cognitive Function in Veterans with Chronic Traumatic Brain Injury: A Case Series, Photobiomodulation, Photomedicine, and Laser Surgery, 10.1089/photob.2018.4489, 37:2, (77-84), Online publication date: 1-Feb-2019. He M, Sun L, Fu X, McDonough S and Chu C (2019) Biodegradabl